Administration of Warfarin Inhibits the Development of Cerulein-Induced Edematous Acute Pancreatitis in Rats
K Konarska-Bajda, P Ceranowicz, J Cieszkowski… - Biomolecules, 2023 - mdpi.com
Acute pancreatitis (AP) is a severe disease with high morbidity and mortality in which
inflammation and coagulation play crucial roles. The development of inflammation leads to …
inflammation and coagulation play crucial roles. The development of inflammation leads to …
Pharmacogenomics of oral antithrombotic drugs
Pharmacogenomics is a relatively recent yet rapidly expanding field of study examining how
genetic variations influence responses to drugs. Antithrombotic drugs include the …
genetic variations influence responses to drugs. Antithrombotic drugs include the …
International warfarin genotype-guided dosing algorithms in the Turkish population and their preventive effects on major and life-threatening hemorrhagic events
S Karaca, NC Bozkurt, T Cesuroglu, M Karaca… - …, 2015 - Future Medicine
Aim: To determine the accuracy of international warfarin pharmacogenetic algorithms
developed on large multiethnic cohorts (comprising more than 1000 subjects) to predict …
developed on large multiethnic cohorts (comprising more than 1000 subjects) to predict …
Introduction and Principles of Pharmacogenomics in Precision Medicine
W Cai, Z Wang - Pharmacogenomics in Precision Medicine: From a …, 2020 - Springer
The individual and ethnic differences of drug effects are very important issues in clinical drug
therapy. They may be caused by genetic variations which mainly come from polymorphisms …
therapy. They may be caused by genetic variations which mainly come from polymorphisms …
Pharmacogenetics of coumarin anticoagulant therapy
RMF van Schie, TI Verhoef, A De Boer… - … and Predictive Genetics …, 2015 - Springer
Coumarins are effective drugs for treatment and prevention of thromboembolic events.
However, their use requires a balancing act between the chance of underdosing which …
However, their use requires a balancing act between the chance of underdosing which …
Personalised medicine: An update on warfarin pharmacogenomics: Part 1 of 2
N Daneshi, M Graham, L Milward - Australian Pharmacist, 2015 - search.informit.org
Warfarin is the most prescribed anticoagulant in Australia. It is used for treatment and
prevention of venous thromboembolism, prevention of thromboembolism in patients with a …
prevention of venous thromboembolism, prevention of thromboembolism in patients with a …
Can pharmacogenetics help patients under chronic treatment with coumarin anticoagulants?
I López, E Sangüesa, Y Vancraenendonck… - Drug Metabolism and …, 2016 - degruyter.com
Vitamin K antagonists are highly effective antithrombotic drugs. However, appropriate
dosing is difficult to establish owing to its narrow therapeutic window as well as widespread …
dosing is difficult to establish owing to its narrow therapeutic window as well as widespread …
[PDF][PDF] Farmacogenetica in de eerstelijnszorg
TEN ToEKomSTvERwaCHTINGEN - NED TIJDSCHR GENEESKD, 2015 - researchgate.net
Bovenstaande casus maakt duidelijk dat het klini-sche gevolgen kan hebben als er geen
therapie op maat ('personalised medicine') wordt gegeven op basis van een …
therapie op maat ('personalised medicine') wordt gegeven op basis van een …
[引用][C] 2.2 Oral anticoagulation treatment in pediatric patients
H Maagdenberg, MB Bierings, A de Boer… - Precision anticoagulation with …